Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00608218
Other study ID # Alves Artist 07/10
Secondary ID
Status Completed
Phase N/A
First received January 23, 2008
Last updated December 2, 2016
Start date January 2008
Est. completion date August 2008

Study information

Verified date September 2016
Source AstraZeneca
Contact n/a
Is FDA regulated No
Health authority Germany: Federal Institute for Drugs and Medical Devices
Study type Observational

Clinical Trial Summary

The aim of the study is to evaluate the efficacy of ciclesonide in patients with persistent asthma over 3 months, especially in the cold season. Ciclesonide will be inhaled by a metered-dose inhaler. The study will provide further data on safety and tolerability of ciclesonide.


Recruitment information / eligibility

Status Completed
Enrollment 2100
Est. completion date August 2008
Est. primary completion date August 2008
Accepts healthy volunteers No
Gender Both
Age group 12 Years and older
Eligibility Main inclusion criteria:

- History of persistent bronchial asthma

Main exclusion criteria:

- Hypersensitive to compounds of Alvesco

- Other criteria as defined in the Summary of Product Characteristics (Fachinformation Chapter 4.3)

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Drug:
Ciclesonide
This is an observational study. Therefore, the physician decides about dosage according to individual needs.

Locations

Country Name City State
Germany "Nycomed Deutschland GmbH" Adendorf
Germany "Nycomed Deutschland GmbH" Arnstadt
Germany "Nycomed Deutschland GmbH" Auerbach
Germany "Nycomed Deutschland GmbH" Augsburg
Germany "Nycomed Deutschland GmbH" Backnang
Germany "Nycomed Deutschland GmbH" Bad Bramstedt
Germany "Nycomed Deutschland GmbH" Bad Kreuznach
Germany "Nycomed Deutschland GmbH" Bad Lippspringe
Germany "Nycomed Deutschland GmbH" Bad Neuenahr-Ahrweiler
Germany "Nycomed Deutschland GmbH" Bad Neustadt
Germany "Nycomed Deutschland GmbH" Bad Soden
Germany "Nycomed Deutschland GmbH" Bad Tölz
Germany "Nycomed Deutschland GmbH" Bautzen
Germany "Nycomed Deutschland GmbH" Bergisch Gladbach
Germany "Nycomed Deutschland GmbH" Berlin
Germany "Nycomed Deutschland GmbH" Berlin
Germany "Nycomed Deutschland GmbH" Berlin
Germany "Nycomed Deutschland GmbH" Berlin
Germany "Nycomed Deutschland GmbH" Berlin
Germany "Nycomed Deutschland GmbH" Berlin
Germany "Nycomed Deutschland GmbH" Berlin
Germany "Nycomed Deutschland GmbH" Berlin
Germany "Nycomed Deutschland GmbH" Berlin
Germany "Nycomed Deutschland GmbH" Berlin
Germany "Nycomed Deutschland GmbH" Berlin
Germany "Nycomed Deutschland GmbH" Berlin
Germany "Nycomed Deutschland GmbH" Berlin
Germany "Nycomed Deutschland GmbH" Berlin
Germany "Nycomed Deutschland GmbH" Berlin
Germany "Nycomed Deutschland GmbH" Bietigheim-Bissingen
Germany "Nycomed Deutschland GmbH" Braunschweig
Germany "Nycomed Deutschland GmbH" Braunschweig
Germany "Nycomed Deutschland GmbH" Bredstedt
Germany "Nycomed Deutschland GmbH" Breisach
Germany "Nycomed Deutschland GmbH" Bremen
Germany "Nycomed Deutschland GmbH" Bremen
Germany "Nycomed Deutschland GmbH" Bremerhaven
Germany "Nycomed Deutschland GmbH" Bremerhaven
Germany "Nycomed Deutschland GmbH" Bröckel
Germany "Nycomed Deutschland GmbH" Bruchsal
Germany "Nycomed Deutschland GmbH" Burgwedel
Germany "Nycomed Deutschland GmbH" Castrop-Rauxel
Germany "Nycomed Deutschland GmbH" Coburg
Germany "Nycomed Deutschland GmbH" Cottbus
Germany "Nycomed Deutschland GmbH" Delitzsch
Germany "Nycomed Deutschland GmbH" Dortmund
Germany "Nycomed Deutschland GmbH" Dortmund
Germany "Nycomed Deutschland GmbH" Dresden
Germany "Nycomed Deutschland GmbH" Dresden
Germany "Nycomed Deutschland GmbH" Duisburg
Germany "Nycomed Deutschland GmbH" Düren
Germany "Nycomed Deutschland GmbH" Düsseldorf
Germany "Nycomed Deutschland GmbH" Eisenach
Germany "Nycomed Deutschland GmbH" Erfurt
Germany "Nycomed Deutschland GmbH" Eschwege
Germany "Nycomed Deutschland GmbH" Finsterwalde
Germany "Nycomed Deutschland GmbH" Flensburg
Germany "Nycomed Deutschland GmbH" Frankfurt
Germany "Nycomed Deutschland GmbH" Freising
Germany "Nycomed Deutschland GmbH" Friedrichshafen
Germany "Nycomed Deutschland GmbH" Fürstenwalde
Germany "Nycomed Deutschland GmbH" Garmisch-Partenkirchen
Germany "Nycomed Deutschland GmbH" Gelsenkirchen
Germany "Nycomed Deutschland GmbH" Gotha
Germany "Nycomed Deutschland GmbH" Greiz
Germany "Nycomed Deutschland GmbH" Hagen
Germany "Nycomed Deutschland GmbH" Halle
Germany "Nycomed Deutschland GmbH" Halle
Germany "Nycomed Deutschland GmbH" Hamburg
Germany "Nycomed Deutschland GmbH" Hamburg
Germany "Nycomed Deutschland GmbH" Hamburg
Germany "Nycomed Deutschland GmbH" Hannover
Germany "Nycomed Deutschland GmbH" Hartha
Germany "Nycomed Deutschland GmbH" Haßloch
Germany "Nycomed Deutschland GmbH" Heidelberg
Germany "Nycomed Deutschland GmbH" Heilbronn
Germany "Nycomed Deutschland GmbH" Herne
Germany "Nycomed Deutschland GmbH" Herten
Germany "Nycomed Deutschland GmbH" Höchstadt
Germany "Nycomed Deutschland GmbH" Hoyerswerda
Germany "Nycomed Deutschland GmbH" Husum
Germany "Nycomed Deutschland GmbH" Jettingen
Germany "Nycomed Deutschland GmbH" Karlsruhe
Germany "Nycomed Deutschland GmbH" Kiel
Germany "Nycomed Deutschland GmbH" Kiel
Germany "Nycomed Deutschland GmbH" Koblenz
Germany "Nycomed Deutschland GmbH" Köln
Germany "Nycomed Deutschland GmbH" Köln
Germany "Nycomed Deutschland GmbH" Konstanz
Germany "Nycomed Deutschland GmbH" Laatzen
Germany "Nycomed Deutschland GmbH" Leipzig
Germany "Nycomed Deutschland GmbH" Leipzig
Germany "Nycomed Deutschland GmbH" Leipzig
Germany "Nycomed Deutschland GmbH" Leipzig
Germany "Nycomed Deutschland GmbH" Limburg
Germany "Nycomed Deutschland GmbH" Lohfelden
Germany "Nycomed Deutschland GmbH" Mainz
Germany "Nycomed Deutschland GmbH" Mainz
Germany "Nycomed Deutschland GmbH" Mannheim
Germany "Nycomed Deutschland GmbH" Mannheim
Germany "Nycomed Deutschland GmbH" Marburg
Germany "Nycomed Deutschland GmbH" Markkleeberg
Germany "Nycomed Deutschland GmbH" Menden
Germany "Nycomed Deutschland GmbH" Minden
Germany "Nycomed Deutschland GmbH" Moers
Germany "Nycomed Deutschland GmbH" Mühlhausen
Germany "Nycomed Deutschland GmbH" München
Germany "Nycomed Deutschland GmbH" Neu Wulmstorf
Germany "Nycomed Deutschland GmbH" Neubrandenburg
Germany "Nycomed Deutschland GmbH" Neumarkt
Germany "Nycomed Deutschland GmbH" Neuruppin
Germany "Nycomed Deutschland GmbH" Neuss
Germany "Nycomed Deutschland GmbH" Nordhausen
Germany "Nycomed Deutschland GmbH" Oberursel
Germany "Nycomed Deutschland GmbH" Offenburg
Germany "Nycomed Deutschland GmbH" Osnabrück
Germany "Nycomed Deutschland GmbH" Plauen
Germany "Nycomed Deutschland GmbH" Radebeul
Germany "Nycomed Deutschland GmbH" Rendsburg
Germany "Nycomed Deutschland GmbH" Rosengarten
Germany "Nycomed Deutschland GmbH" Rostock
Germany "Nycomed Deutschland GmbH" Saalfeld
Germany "Nycomed Deutschland GmbH" Saarbrücken
Germany "Nycomed Deutschland GmbH" Saarlouis
Germany "Nycomed Deutschland GmbH" Salzgitter
Germany "Nycomed Deutschland GmbH" Schmölln
Germany "Nycomed Deutschland GmbH" Schwalmtal
Germany "Nycomed Deutschland GmbH" Schwarmstedt
Germany "Nycomed Deutschland GmbH" Schwerin
Germany "Nycomed Deutschland GmbH" Siegen
Germany "Nycomed Deutschland GmbH" Sinsheim
Germany "Nycomed Deutschland GmbH" Solingen
Germany "Nycomed Deutschland GmbH" Sonneberg
Germany "Nycomed Deutschland GmbH" Stadthagen
Germany "Nycomed Deutschland GmbH" Starnberg
Germany "Nycomed Deutschland GmbH" Steißlingen
Germany "Nycomed Deutschland GmbH" Straelen
Germany "Nycomed Deutschland GmbH" Stuttgart
Germany "Nycomed Deutschland GmbH" Stuttgart
Germany "Nycomed Deutschland GmbH" Stuttgart
Germany "Nycomed Deutschland GmbH" Teterow
Germany "Nycomed Deutschland GmbH" Teuchern
Germany "Nycomed Deutschland GmbH" Uelzen
Germany "Nycomed Deutschland GmbH" Ulm
Germany "Nycomed Deutschland GmbH" Umkirch
Germany "Nycomed Deutschland GmbH" Villingen-Schwenningen
Germany "Nycomed Deutschland GmbH" Vilshofen
Germany "Nycomed Deutschland GmbH" Wallertheim
Germany "Nycomed Deutschland GmbH" Wilhelmshaven
Germany "Nycomed Deutschland GmbH" Witten
Germany "Nycomed Deutschland GmbH" Wörrstadt
Germany "Nycomed Deutschland GmbH" Wörth
Germany "Nycomed Deutschland GmbH" Würzburg

Sponsors (1)

Lead Sponsor Collaborator
AstraZeneca

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary FEV1, symptom score assessment within 3 months
Secondary Handling of the metered-dose inhaler, safety and tolerability within 3 months
See also
  Status Clinical Trial Phase
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device